A Phase II Evaluation of Belinostat and Carboplatin in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

BACKGROUND: Patients with recurrent ovarian cancer have limited options, especially in the context of relapse less than six months from primary platinum-based therapy. This Gynecologic Oncology Group (GOG) study was conducted to evaluate the impact of the histone deacetylase inhibitor, belinostat, i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Dizon, Don S., Blessing, John A., Penson, Richard T., Drake, Richard D., Walker, Joan L., Johnston, Carolyn M., DiSilvestro, Paul A., Fader, Amanda Nickles
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3330705/
https://ncbi.nlm.nih.gov/pubmed/22366594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2012.02.019
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia